Shareholders Turn Down Tender Offer to Take BioCanCell Private Post author:Sam Post published:December 27, 2017 Post category:BioPharma Approximately 5.9 million shares were necessary for the tender to be accepted. Source: BioSpace You Might Also Like Cutera Strengthens Leadership Team With Two Key Executive Appointments August 20, 2017 Novartis' Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data … December 26, 2017 Astellas Takes Out Massachusetts' Biotech Mitobridge in $390M Deal November 30, 2017
Novartis' Tasigna Wins FDA Nod for First and Only CML Therapy With Treatment-Free Remission Data … December 26, 2017
